Literature DB >> 20618409

Brain stimulation for the treatment of epilepsy.

Barbara C Jobst1, Terrance M Darcey, Vijay M Thadani, David W Roberts.   

Abstract

Direct brain stimulation is an emerging treatment of epilepsy. Scheduled or responsive stimulation has been applied. The most explored targets for scheduled stimulation are the anterior nucleus of the thalamus and the hippocampus. The anterior nucleus of the thalamus was studied in a large multicenter trial. There was a significant seizure reduction with the stimulator "on" versus "off" during several months after stimulator implantation. The hippocampus as stimulation target has not yet been studied in a large randomized trial. Responsive stimulation applies a stimulus whenever epileptiform activity occurs. It requires on-line detection of epileptiform activity. This concept is based on the observation that epileptiform activity during functional mapping can be aborted by brief pulses of cortical stimulation. Current technology is able to detect seizure activity intracranially on-line and delivers a high frequency stimulus if epileptiform activity is detected. A large randomized multicenter trial has been conducted testing this system for focal epilepsy.

Entities:  

Mesh:

Year:  2010        PMID: 20618409     DOI: 10.1111/j.1528-1167.2010.02618.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Epilepsy and the consciousness system: transient vegetative state?

Authors:  Hal Blumenfeld
Journal:  Neurol Clin       Date:  2011-11       Impact factor: 3.806

2.  Corpus callosum low-frequency stimulation suppresses seizures in an acute rat model of focal cortical seizures.

Authors:  Nicholas H Couturier; Dominique M Durand
Journal:  Epilepsia       Date:  2018-11-13       Impact factor: 5.864

3.  Computational modeling of epilepsy.

Authors:  Marianne Case; Ivan Soltesz
Journal:  Epilepsia       Date:  2011-10       Impact factor: 5.864

4.  Low frequency stimulation of ventral hippocampal commissures reduces seizures in a rat model of chronic temporal lobe epilepsy.

Authors:  Saifur Rashid; Gerald Pho; Michael Czigler; Mary A Werz; Dominique M Durand
Journal:  Epilepsia       Date:  2011-12-09       Impact factor: 5.864

5.  Seizure reduction through interneuron-mediated entrainment using low frequency optical stimulation.

Authors:  Thomas P Ladas; Chia-Chu Chiang; Luis E Gonzalez-Reyes; Theodore Nowak; Dominique M Durand
Journal:  Exp Neurol       Date:  2015-04-08       Impact factor: 5.330

6.  UKF-based closed loop iterative learning control of epileptiform wave in a neural mass model.

Authors:  Bonan Shan; Jiang Wang; Bin Deng; Xile Wei; Haitao Yu; Huiyan Li
Journal:  Cogn Neurodyn       Date:  2014-08-20       Impact factor: 5.082

7.  Fiber tract stimulation can reduce epileptiform activity in an in-vitro bilateral hippocampal slice preparation.

Authors:  Sheela Toprani; Dominique M Durand
Journal:  Exp Neurol       Date:  2012-11-01       Impact factor: 5.330

Review 8.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

Review 9.  Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease.

Authors:  Ying-Chang Wu; Ying-Siou Liao; Wen-Hsiu Yeh; Sheng-Fu Liang; Fu-Zen Shaw
Journal:  Front Neurosci       Date:  2021-06-14       Impact factor: 4.677

10.  Neural fragility as an EEG marker of the seizure onset zone.

Authors:  Jorge Gonzalez-Martinez; Sridevi V Sarma; Adam Li; Chester Huynh; Zachary Fitzgerald; Iahn Cajigas; Damian Brusko; Jonathan Jagid; Angel O Claudio; Andres M Kanner; Jennifer Hopp; Stephanie Chen; Jennifer Haagensen; Emily Johnson; William Anderson; Nathan Crone; Sara Inati; Kareem A Zaghloul; Juan Bulacio
Journal:  Nat Neurosci       Date:  2021-08-05       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.